AMPH Amphastar Pharmaceuticals, Inc.

18.40
+0.4  (2.22%)
Previous Close 18.00
Open 18.20
Price To book 2.52
Market Cap 846.82M
Shares 46,023,000
Volume 452,209
Short Ratio 5.65
Av. Daily Volume 358,571

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Albuterol DPI
Asthma
CRL announced February 21, 2017.
Naloxone Intranasal
Opioid overdose
CRL issued December 27, 2016.
Primatene Mist (epinephrine inhalation aerosol)
Asthma

Latest News

  1. FDA Rejects Amphastar's Nasal Opioid Overdose Drug
  2. Amphastar Pharma stock plummets 16% after FDA fails to approve nasal spray for opioid overdoses
  3. FDA rejects Amphastar's nasal version of opioid overdose treatment
  4. 6:02 am Amphastar Pharmaceuticals receives a CRL for its NDA for for Naloxone Hydrochloride 2mg/0.5mL Nasal Spray; CRL identifies issues including user human factors study, device evaluation, and other items that need to be addressed before
  5. Amphastar Announces the Receipt of a CRL for Intranasal Naloxone for the Emergency Treatment of Opioid Overdose
  6. Lifshitz & Miller Law Firm Announces Investigation of Ally Financial Inc., Amphastar Pharmaceuticals, Inc., Lannett Company, Inc., Live Ventures Incorporated, MiMedx Group, Inc., Seattle Genetics, Inc., Teligent, Inc., TerraVia Holdings, In
  7. 6 Major FDA Decisions and Biopharma Catalysts Coming in January and February
  8. IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of Amphastar Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm
  9. SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amphastar Pharmaceuticals, Inc. - AMPH
  10. Pharma Stock Roundup: Cempra Plunges to 52-Week Low, Shire Drug Label Expanded
  11. Amphastar Pharmaceuticals, Inc. – Value Analysis (NASDAQ:AMPH) : December 29, 2016
  12. IMPORTANT INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Amphastar Pharmaceuticals, Inc. and Advises Investors with Losses to Contact the Firm
  13. Amphastar Stock Down on CRL for Asthma Drug in the U.S.
  14. SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Amphastar Pharmaceuticals, Inc. (AMPH)
  15. Amphastar Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : AMPH-US : December 28, 2016
  16. SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Amphastar Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
  17. SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amphastar Pharmaceuticals, Inc. - AMPH
  18. Amphastar Slides After Receiving CRL From the FDA
  19. AMPHASTAR PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits